Baird takes stake in Prescient Healthcare Group
Baird Capital has acquired a stake in London-based Prescient Healthcare Group, a product strategy consultancy for the biopharmaceutical sector. No financial terms were disclosed. In conjunction with the deal, Baird Capital's Andrew Ferguson and John DiGiovanni have been added to Prescient's board of directors while Nick Edwards will become chairman.


